Answers are grounded in this paper and cite their sources.
CRISPR technology has revolutionized gene editing, with implications across various fields, including oncology. In oral cancer research, CRISPR offers unprecedented precision in targeting and modifying cancer-associated genes. However, despite its promise, significant challenges prevent its widespread clinical use. This Perspective article will focus on the critical challenges of CRISPR implementation in oral oncology, such as the technical limitations, ethical concerns, and the need for innovative delivery mechanisms. We propose that addressing these issues could pave the way for more effective and personalized cancer treatments.
No takes yet. Share an insight, caveat, or question.
Selvam et al. (2024) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: